Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 5
Submit an article Journal homepage
922
Views
53
CrossRef citations to date
0
Altmetric
Original Article

Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors

Tenglong TangDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; ;Department of Minimally Invasive Surgery, The Second Xiangya Hospital of Central South University, Changsha, China;
,
Hamzah Abu-SbeihDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;
,
Wenyi LuoDivision of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;
,
Phillip LumDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;
,
Wei QiaoDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
,
Robert S. BresalierDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;
,
David M. RichardsDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA;
&
Yinghong WangDepartment of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Correspondence[email protected]
 show all
Pages 538-545 | Received 10 Feb 2019, Accepted 04 Mar 2019, Published online: 13 May 2019

Citations (53)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Wenfang Xiong, Zhenzhen Yang & Youxiang Chen. Sintilimab-induced severe erosive hemorrhagic gastritis and pyloric obstruction: a case report and literature review. Immunotherapy 0:0, pages 1-7.
Read now

Articles from other publishers (52)

Matthew J. Townsend, Isaac J. Benque, Michael Li & Shilpa Grover. (2024) Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors. Alimentary Pharmacology & Therapeutics 59:11, pages 1350-1365.
Crossref
Tian Lan, Wen-Juan Yang & Huan Tong. (2024) An Overlooked Cause of Severe Gastritis. Gastroenterology 166:5, pages e1-e4.
Crossref
Mar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera & María-Carlota Londoño. (2024) Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU. Gastroenterología y Hepatología 47:4, pages 401-432.
Crossref
Mar Riveiro-Barciela, Sabela Carballal, Álvaro Díaz-González, Míriam Mañosa, Javier Gallego-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera & María-Carlota Londoño. (2024) Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU. Gastroenterología y Hepatología (English Edition) 47:4, pages 401-432.
Crossref
Kevin Mok, Claudia Wu, Stephen Chan, Grace Wong, Vincent Wai-Sun Wong, Brigette Ma & Rashid Lui. (2024) Clinical Management of Gastrointestinal and Liver Toxicities of Immune Checkpoint Inhibitors. Clinical Colorectal Cancer 23:1, pages 4-13.
Crossref
Mar Riveiro-Barciela, Sabela carballal, Álvaro Díaz-González, Miriam Mañosa, Javier Gallgo-Plazas, Joaquín Cubiella, Paula Jiménez-Fonseca, María Varela, Luis Menchén, Bruno Sangro, Ana Fernández-Montes, Francisco Mesonero, Miguel Ángel Rodríguez-Gandía, Fernando Rivera & María-Carlota Londoño. (2024) Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU. Revista Española de Enfermedades Digestivas.
Crossref
Clément Bresteau, Pauline Bonnet, Caroline Robert, Charlotte Mussini, Philippe Saiag, Bruno Buecher, Celeste Lebbe, Matthieu Allez, Robert Benamouzig, Hervé Hagège, Hakim Bécheur, Antoine Meyer & Franck Carbonnel. (2023) Serious immune‐related upper gastrointestinal toxicity of immune checkpoint inhibitors: a multicenter case series. Journal of Gastroenterology and Hepatology 38:12, pages 2104-2110.
Crossref
James Michael Mitchell & Dipti M. Karamchandani. (2023) Histopathologic Manifestations of Immune Checkpoint Inhibitor Therapy-Associated Gastrointestinal Tract Injury. Surgical Pathology Clinics 16:4, pages 703-718.
Crossref
Sonja C. Simon & Jochen S. Utikal. (2023) Nebenwirkungen frühzeitig erkennen und erfolgreich managen. Deutsche Dermatologie 71:10, pages 812-820.
Crossref
Andrew G. Kuang, Gabriel Sperling, Tom Z. Liang, Yang Lu, Dongfeng Tan, Kathryn Bollin, Douglas B. Johnson, Joanna-Grace M. Manzano, Malek Shatila, Anusha S. Thomas, John A. Thompson, Hao Chi Zhang & Yinghong Wang. (2023) Sclerosing mesenteritis following immune checkpoint inhibitor therapy. Journal of Cancer Research and Clinical Oncology 149:11, pages 9221-9227.
Crossref
Natalie Farha, Muhammad Salman Faisal, Daniela S Allende, Joseph Sleiman, Ravi Shah, Nicole Farha, Pauline Funchain & Jessica R Philpott. (2023) Characteristics of Immune Checkpoint Inhibitor-Associated Gastritis: Report from a Major Tertiary Care Center. The Oncologist 28:8, pages 706-713.
Crossref
Valérie Desmedt, Aranzazu Jauregui-Amezaga, Liselotte Fierens, Sandrine Aspeslagh, Jeroen Dekervel, Els Wauters, Marc Peeters, Joao Sabino, Lara Crapé, Michael Somers, Anne Hoorens, Joris Dutré & Triana Lobatón. (2023) Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus. European Journal of Cancer 187, pages 36-57.
Crossref
Austin R. Thomas, Mostafa Eyada, Miho Kono, Krishnavathana Varatharajalu, Yang Lu, Guofan Xu, Kavea Panneerselvam, Malek Shatila, Mehmet Altan, Jennifer Wang, John A. Thompson, Hao Chi Zhang, Muhammad Ali Khan, Gottumukkala S. Raju, Anusha S. Thomas & Yinghong Wang. (2022) Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignancies. Journal of Cancer Research and Clinical Oncology 149:8, pages 4805-4816.
Crossref
Shefali Amin, Salina Munankami, Parth Desai, John Altomare & Nirav Shah. (2023) Immune Checkpoint Inhibitor-Induced Lymphocytic Esophagitis. Cureus.
Crossref
Camille Boulagnon-Rombi, Charlotte Dufour & Denis Chatelain. (2023) Lésions iatrogènes du tube digestif vues par le pathologiste. Annales de Pathologie 43:3, pages 236-251.
Crossref
Edouard Guenzi & Nicolas Poté. (2023) « …ites » lymphocytaires, de l’œsophage au côlon. Annales de Pathologie 43:3, pages 266-279.
Crossref
Tomoyuki Otsuka, Yoshiko Hashii, Sei Murayama, Yasunobu Ishizuka, Yoshiki Kojitani, Minako Nishio & Toshihiro Kudo. (2023) Checkpoint inhibitor-induced gastritis followed by delayed severe hepatitis in a patient with lung metastases of head and neck squamous cell carcinoma: a case report. Frontiers in Oncology 13.
Crossref
Diana Paredes-Ruiz, Flora López-López, Juan Antonio Núñez-Sobrino, Carlos Gómez-Martin, Carmen Díaz-Pedroche & Manuel Lizasoain. (2023) Reactivación de citomegalovirus en pacientes con gastritis inmunomediada. Enfermedades infecciosas y microbiologia clinica (English ed.) 41:5, pages 298-300.
Crossref
Diana Paredes-Ruiz, Flora López-López, Juan Antonio Núñez-Sobrino, Carlos Gómez-Martin, Carmen Díaz-Pedroche & Manuel Lizasoain. (2023) Reactivación de citomegalovirus en pacientes con gastritis inmunomediada. Enfermedades Infecciosas y Microbiología Clínica 41:5, pages 298-300.
Crossref
Dipti M. Karamchandani, Lindsey Westbrook & Christina A. Arnold. (2023) Drug-induced digestive tract injury: decoding some invisible offenders. Human Pathology 132, pages 135-148.
Crossref
Aneesha Haryal, Matthew J. Townsend, Vinitha Baskaran, Padmavathi Srivoleti, Anita Giobbie‐Hurder, Jordan S. Sack, Raymond A. Isidro, Nicole R. LeBoeuf, Elizabeth I. Buchbinder, F. Stephen Hodi & Shilpa Grover. (2022) Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course. Cancer 129:3, pages 367-375.
Crossref
Steven Nicolaides & Alex Boussioutas. (2023) Immune-Related Adverse Events of the Gastrointestinal System. Cancers 15:3, pages 691.
Crossref
J. Haanen, M. Obeid, L. Spain, F. Carbonnel, Y. Wang, C. Robert, A.R. Lyon, W. Wick, M. Kostine, S. Peters, K. Jordan & J. Larkin. (2022) Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology 33:12, pages 1217-1238.
Crossref
Binbin Zheng-Lin, David M. Faleck & James J. Harding. (2022) Subacute Abdominal Pain in a Patient With Chronic Liver Disease and Hepatocellular Carcinoma. JAMA Oncology 8:11, pages 1688.
Crossref
Michiel C. Mommersteeg, Bing Ting Yu, Thierry P. P. van den Bosch, Johan H. von der Thüsen, Ernst J. Kuipers, Michael Doukas, Manon C. W. Spaander, Maikel P. Peppelenbosch & Gwenny M. Fuhler. (2022) Constitutive programmed death ligand 1 expression protects gastric G‐cells from Helicobacter pylori –induced inflammation . Helicobacter 27:5.
Crossref
Adham Obeidat, Krixie Silangcruz, Landon Kozai, Eric Wien, Yu Fujiwara & Yoshito Nishimura. (2022) Clinical Characteristics and Outcomes of Gastritis Associated With Immune Checkpoint Inhibitors: Scoping Review. Journal of Immunotherapy 45:8, pages 363-369.
Crossref
Daniel J. Hughes, Manil Subesinghe, Benjamin Taylor, Andrea Bille, James Spicer, Sophie Papa, Vicky Goh & Gary J. R. Cook. (2022) 18 F FDG PET/CT and Novel Molecular Imaging for Directing Immunotherapy in Cancer . Radiology 304:2, pages 246-264.
Crossref
Qi Ai, Wen Chen, Yonggui Li & Guoqing Li. (2022) Upper Gastrointestinal Tract IrAEs: A Case Report About Sintilimab-Induced Acute Erosive Hemorrhagic Gastritis. Frontiers in Immunology 13.
Crossref
Rachele Del Sordo, Umberto Volta, Vassilios Lougaris, Paola Parente, Angelo Sidoni, Mattia Facchetti, Gabrio Bassotti, Illuminato Carosi, Celeste Clemente & Vincenzo Villanacci. (2022) Histological Features of Celiac-Disease-like Conditions Related to Immune Checkpoint Inhibitors Therapy: A Signal to Keep in Mind for Pathologists. Diagnostics 12:2, pages 395.
Crossref
Baoqing Chen, Chen Yang, Mihnea P. Dragomir, Dongmei Chi, Wenyan Chen, David Horst, George A. Calin & Qiaoqiao Li. (2022) Association of proton pump inhibitor use with survival outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Therapeutic Advances in Medical Oncology 14, pages 175883592211117.
Crossref
Catarina O’Neill, Rui Mendo & Pedro C. Figueiredo. (2022) Immune Checkpoint Inhibitor-Induced Gastroduodenitis: Recurrence after Rechallenge with Pembrolizumab. GE - Portuguese Journal of Gastroenterology 29:1, pages 3-4.
Crossref
M. Lisa Zhang & Vikram Deshpande. (2022) Histopathology of Gastrointestinal Immune-related Adverse Events. American Journal of Surgical Pathology 46:1, pages e15-e26.
Crossref
Anusha Shirwaikar Thomas & Yinghong Wang. 2022. Managing Immunotherapy Related Organ Toxicities. Managing Immunotherapy Related Organ Toxicities 81 96 .
Zongshan Lai, Yi Tat Tong & Dongfeng Tan. 2022. Managing Immunotherapy Related Organ Toxicities. Managing Immunotherapy Related Organ Toxicities 265 273 .
Bryan J. Schneider, Jarushka Naidoo, Bianca D. Santomasso, Christina Lacchetti, Sherry Adkins, Milan Anadkat, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Caterino, Ian Chau, Marianne J. Davies, Marc S. Ernstoff, Leslie Fecher, Monalisa Ghosh, Ishmael Jaiyesimi, Jennifer S. Mammen, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura D. Porter, Cristina A. Reichner, Carole Seigel, Jung-Min Song, Alexander Spira, Maria Suarez-Almazor, Umang Swami, John A. Thompson, Praveen Vikas, Yinghong Wang, Jeffrey S. Weber, Pauline Funchain & Kathryn Bollin. (2021) Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update. Journal of Clinical Oncology 39:36, pages 4073-4126.
Crossref
Jake S. JacobBarbara E. DutraVictor Garcia-RodriguezKavea PanneerselvamFiyinfoluwa O. AbrahamFangwen ZouWeijie MaPetros Grivas, John A. Thompson, Mehmet Altan, Isabella C. Glitza OlivaHao Chi ZhangAnusha S. ThomasYinghong Wang. (2021) Clinical Characteristics and Outcomes of Oral Mucositis Associated With Immune Checkpoint Inhibitors in Patients With Cancer. Journal of the National Comprehensive Cancer Network 19:12, pages 1415-1424.
Crossref
Kavea PanneerselvamRajan N. Amin, Dongguang WeiDongfeng TanPhillip J. Lum, Hao Chi Zhang, David M. Richards, Mehmet Altan, Petros GrivasJohn A. ThompsonAnusha S. Thomas & Yinghong Wang. (2021) Clinicopathologic Features, Treatment Response, and Outcomes of Immune Checkpoint Inhibitor–Related Esophagitis. Journal of the National Comprehensive Cancer Network 19:8, pages 896-904.
Crossref
Anusha Bapatla, Tooba Tariq, Maryam Bilal Haider & Bashar Mohamad. (2021) Atezolizumab, a PD-L1 Inhibitor: An Association of Bleeding Gastric Ulcer With Its Use. Cureus.
Crossref
Julie R Brahmer, Hamzah Abu-Sbeih, Paolo Antonio Ascierto, Jill Brufsky, Laura C Cappelli, Frank B Cortazar, David E Gerber, Lamya Hamad, Eric Hansen, Douglas B Johnson, Mario E Lacouture, Gregory A Masters, Jarushka Naidoo, Michele Nanni, Miguel-Angel Perales, Igor Puzanov, Bianca D Santomasso, Satish P Shanbhag, Rajeev Sharma, Dimitra Skondra, Jeffrey A Sosman, Michelle Turner & Marc S Ernstoff. (2021) Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. Journal for ImmunoTherapy of Cancer 9:6, pages e002435.
Crossref
Pallavi A. Patil & Xuchen Zhang. (2021) Pathologic Manifestations of Gastrointestinal and Hepatobiliary Injury in Immune Checkpoint Inhibitor Therapy. Archives of Pathology & Laboratory Medicine 145:5, pages 571-582.
Crossref
Kshitij Arora, M. Lisa Zhang, Maria Belén Goiburú-Chenu & Jonathan England. (2021) Pathology of immune checkpoint inhibitor-induced injury of the gastrointestinal tract and hepatobiliary system. Diagnostic Histopathology 27:2, pages 62-68.
Crossref
Rachel Woodford, Karen Briscoe, Richard Tustin & Ankit Jain. (2021) Immunotherapy-related gastritis: Two case reports and literature review. Clinical Medicine Insights: Oncology 15, pages 117955492110285.
Crossref
Ian Brown, Mark Bettington & Christophe Rosty. (2020) The role of histopathology in the diagnosis and management of coeliac disease and other malabsorptive conditions. Histopathology 78:1, pages 88-105.
Crossref
Anusha S. Thomas & Yinghong Wang. 2021. Immunotherapy. Immunotherapy 331 337 .
Frank W. Chen, Anne F. Liu, Amitabh Srivastava, Elizabeth Buchbinder & Shilpa Grover. (2020) Checkpoint inhibitor induced esophagitis with documented resolution on infliximab. Current Problems in Cancer: Case Reports 2, pages 100029.
Crossref
Vincent Ting Fung Cheung & Oliver Brain. (2020) Immunotherapy induced enterocolitis and gastritis – What to do and when?. Best Practice & Research Clinical Gastroenterology 48-49, pages 101703.
Crossref
Nick Powell, Hajir Ibraheim, Tim Raine, Richard A Speight, Sophie Papa, Oliver Brain, Michael Green, Mark A Samaan, Lavinia Spain, Nadia Yousaf, Nikki Hunter, Lucy Eldridge, Polychronis Pavlidis, Peter Irving, Bu'Hussain Hayee, Samra Turajlic, James Larkin, James O Lindsay & Martin Gore. (2020) British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis. The Lancet Gastroenterology & Hepatology 5:7, pages 679-697.
Crossref
Bei Tan, Yue Li, Yan Xu, Minjiang Chen, Mengzhao Wang & Jiaming Qian. (2020) Recognition and management of the gastrointestinal and hepatic immune‐related adverse events. Asia-Pacific Journal of Clinical Oncology 16:3, pages 95-102.
Crossref
Yawen Zheng, Wei Gao, Denial E. Spratt, Yuping Sun & Ligang Xing. (2020) Management of gastrointestinal perforation related to radiation. International Journal of Clinical Oncology 25:6, pages 1010-1015.
Crossref
Helene Hjorth Vindum, Jørgen S Agnholt, Anders Winther Moelby Nielsen, Mette Bak Nielsen & Henrik Schmidt. (2020) Severe steroid refractory gastritis induced by Nivolumab: A case report. World Journal of Gastroenterology 26:16, pages 1971-1978.
Crossref
Hamzah Abu-Sbeih & Yinghong Wang. (2020) Management Considerations for Immune Checkpoint Inhibitor–Induced Enterocolitis Based on Management of Inflammatory Bowel Disease. Inflammatory Bowel Diseases 26:5, pages 662-668.
Crossref
Hamzah Abu-Sbeih & Yinghong Wang. 2020. Immunotherapy. Immunotherapy 247 253 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.